Skip navigation.
Home

archives

HOT OFF THE PRESS

... colitis. Symptoms include chronic pain, diarrhea, weight loss and, in long-term cases, an increased risk of colon cancer.

IBD isn't well-understood, but researchers suspect it's caused by an o ...

Juice may help colon

... colitis who drank aloe vera juice, nine went into remission and 11 noticed an improvement in symptoms.

Most benefits are anecdotal; there is little substantive evidence to support internal benef ...

Oscient Pharmaceuticals' FACTIVE Tablets Subject of Poster ...

... Breaking News: Oscient Pharmaceuticals' FACTIVE Tablets Subject of Poster Presentations at European Congress of Clinical Microbiology and Infectious Diseases; Leading European Conference Draws Key S ...

FDA Gives J&J Drug Priority Review

... colitis.

Copyright Notice & Privacy Policy ...

For Your Information

... ...

FDA Grants Priority Review of REMICADE for the Treatment of ...

... colitis (UC), making it the only biologic indicated for the treatment of both types of inflammatory bowel disease (IBD) in adults.

REACH was a randomized, multicenter, open-label study designed ...

FDA Grants Priority Review of REMICADE(R) for the Treatment of ...

... FDA Grants Priority Review of REMICADE(R) for the Treatment of Children with Active Crohn's Disease

Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the ...

FDA grants priority review of Remicade®

... colitis (UC), and ankylosing spondylitis (AS). The safety and efficacy of REMICADE have been well established in clinical trials over the past 13 years and through commercial experience with more than ...

The Open Press Free Press Release News Wire

... colitis,this prevents me from eating a high fiber diet to control my blood sugar and adds to the cost of my diabetes management.

Yes, help today is only a mouse click away - Daniel Haszard

FDA grants Remicade priority review for pediatric use

... '); } else { document.write(''); } } //--> Investor's Business Daily: Breaking News '); //-->

The seemingly tired, old bull market advanced in the fourth quarter as strong fundamentals ou ...

FDA Grants Priority Review of REMICADE® for Children With Active ...

... EndoNurse - FDA Grants Priority Review of REMICADE® for Children With Active Crohn's

FDA Grants Priority Review of REMICADE® for Children With Active Crohn's

US Endoscopy Launches Roth ...

FDA Grants Priority Review of Remicade (Infliximab) for the ...

... News - FDA Grants Priority Review of Remicade (Infliximab) for the Treatment of Children with Active Crohn's Disease

All contents Copyright (c) 1995-2006 Doctor's Guide Publishing Limited. Al ...